Liquid-Liquid Phase Separation in Major Hallmarks of Cancer
- PMID: 40969122
- DOI: 10.1111/cpr.70122
Liquid-Liquid Phase Separation in Major Hallmarks of Cancer
Abstract
The malignant transformation of cancer cells is underpinned by the dysregulation of essential cellular processes, including genome stability maintenance, DNA repair, transcriptional control and signal transduction. These processes are not randomly distributed but are spatiotemporally coordinated through dynamic molecular assemblies. Recent advances have highlighted the pivotal role of biomolecular condensates, membraneless compartments formed via liquid-liquid phase separation (LLPS), in compartmentalising and regulating these key functions. LLPS enables the concentration and organisation of proteins and nucleic acids, creating distinct biochemical environments that facilitate cellular decision-making. Importantly, aberrant phase separation has been increasingly implicated in the acquisition of cancer hallmarks, such as sustained proliferative signalling, resistance to cell death and immune evasion. In this review, we summarise the physicochemical principles of LLPS, examine its emerging roles in oncogenic transformation and discuss the therapeutic potential of targeting phase separation in cancer. Our findings highlight LLPS as a novel and versatile regulatory layer in tumour biology and an emerging frontier in precision oncology.
Keywords: biomolecular condensates; cancer; cancer therapeutics; dysregulated state; liquid–liquid phase separation.
© 2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
References
-
- D. Hanahan and R. A. Weinberg, “The Hallmarks of Cancer,” Cell 100, no. 1 (2000): 57–70, https://doi.org/10.1016/s0092‐8674(00)81683‐9.
-
- D. Hanahan and R. A. Weinberg, “Hallmarks of Cancer: The Next Generation,” Cell 144, no. 5 (2011): 646–674, https://doi.org/10.1016/j.cell.2011.02.013.
-
- D. Hanahan, “Hallmarks of Cancer: New Dimensions,” Cancer Discovery 12, no. 1 (2022): 31–46, https://doi.org/10.1158/2159‐8290.CD‐21‐1059.
-
- F. Sanchez‐Vega, M. Mina, J. Armenia, et al., “Oncogenic Signaling Pathways in the Cancer Genome Atlas,” Cell 173, no. 2 (2018): 321–337.e10, https://doi.org/10.1016/j.cell.2018.03.035.
-
- R. Sever and J. S. Brugge, “Signal Transduction in Cancer,” Cold Spring Harbor Perspectives in Medicine 5, no. 4 (2015): a006098, https://doi.org/10.1101/cshperspect.a006098.
Publication types
Grants and funding
- 82472791/National Natural Science Foundation of China
- 82173281/National Natural Science Foundation of China
- 82172948/National Natural Science Foundation of China
- 82173282/National Natural Science Foundation of China
- 82172577/National Natural Science Foundation of China
- 82373006/National Natural Science Foundation of China
- 82303102/National Natural Science Foundation of China
- U21A20374/National Natural Science Foundation of China
- 20ZR1471100/Shanghai Municipal Science and Technology Commission
- 20224Z0006/Excellence Project of the Shanghai Municipal Health Commission
- YDZX20243100002003/Science and Technology Commission of Shanghai Municipality
- 22YF1409000/Sailing Project of the Science and Technology Commission of Shanghai Municipality
- SACA-CY21C03/Foundation of the Shanghai Anti-Cancer Association
- 20234Y0119/Clinical Research Project of Health Industry of the Shanghai Municipal Health Commission
- SACA-AX202317/Shanghai Anticancer Association SOAR PROJECT
LinkOut - more resources
Full Text Sources